Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 60 entries
Sorted by: Best Match Show Resources per page
Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Contemporary clinical trials

Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS.
PMID: 26275339
Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12.

Annual influenza vaccination reduces the risks of influenza when the vaccines are well matched to circulating strains, but development of an approach that induces broader and more durable immune responses would be beneficial. We conducted two companion Phase 1...

Cite
Ledgerwood JE, Hu Z, Costner P, et al. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015;44:112-118doi: 10.1016/j.cct.2015.08.006.
Ledgerwood, J. E., Hu, Z., Costner, P., Yamshchikov, G., Enama, M. E., Plummer, S., Hendel, C. S., Holman, L., Larkin, B., Gordon, I., Bailer, R. T., Poretz, D. M., Sarwar, U., Kabadi, A., Koup, R., Mascola, J. R., Graham, B. S. (2015). Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemporary clinical trials, 44112-118. https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood, Julie E, et al. "Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost." Contemporary clinical trials vol. 44 (2015): 112-118. doi: https://doi.org/10.1016/j.cct.2015.08.006
Ledgerwood JE, Hu Z, Costner P, Yamshchikov G, Enama ME, Plummer S, Hendel CS, Holman L, Larkin B, Gordon I, Bailer RT, Poretz DM, Sarwar U, Kabadi A, Koup R, Mascola JR, Graham BS. Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost. Contemp Clin Trials. 2015 Sep;44:112-118. doi: 10.1016/j.cct.2015.08.006. Epub 2015 Aug 12. PMID: 26275339; PMCID: PMC4751067.
Copy Download .nbib Format: NLM
Antibody-Based Strategies to Prevent and Treat Influenza.

Frontiers in immunology

Shriver Z, Trevejo JM, Sasisekharan R.
PMID: 26217334
Front Immunol. 2015 Jul 13;6:315. doi: 10.3389/fimmu.2015.00315. eCollection 2015.

Passive immunization using antibodies is a promising alternative to other antiviral treatment options. The potential for seasonal protection arising from a single injection of antibodies is appealing and has been pursued for a number of infectious agents. However, until...

Cite
Shriver Z, Trevejo JM, Sasisekharan R. Antibody-Based Strategies to Prevent and Treat Influenza. Front Immunol. 2015;6:315doi: 10.3389/fimmu.2015.00315.
Shriver, Z., Trevejo, J. M., & Sasisekharan, R. (2015). Antibody-Based Strategies to Prevent and Treat Influenza. Frontiers in immunology, 6315. https://doi.org/10.3389/fimmu.2015.00315
Shriver, Zachary, et al. "Antibody-Based Strategies to Prevent and Treat Influenza." Frontiers in immunology vol. 6 (2015): 315. doi: https://doi.org/10.3389/fimmu.2015.00315
Shriver Z, Trevejo JM, Sasisekharan R. Antibody-Based Strategies to Prevent and Treat Influenza. Front Immunol. 2015 Jul 13;6:315. doi: 10.3389/fimmu.2015.00315. eCollection 2015. PMID: 26217334; PMCID: PMC4500096.
Copy Download .nbib Format: NLM
Pathogenesis and transmission of kilham rat virus infection in rats.

Infection and immunity

Novotny JF, Hetrick FM.
PMID: 16557835
Infect Immun. 1970 Sep;2(3):298-303. doi: 10.1128/iai.2.3.298-303.1970.

The Kilham rat virus (RV) was found to produce mortality in newborn rats after intracerebral, intravenous, or subcutaneous administration of virus. Both infectious virus and viral hemagglutinins were detected in a variety of tissues and in the blood and...

Cite
Novotny JF, Hetrick FM. Pathogenesis and transmission of kilham rat virus infection in rats. Infect Immun. 1970;2(3):298-303doi: 10.1128/iai.2.3.298-303.1970.
Novotny, J. F., & Hetrick, F. M. (1970). Pathogenesis and transmission of kilham rat virus infection in rats. Infection and immunity, 2(3), 298-303. https://doi.org/10.1128/iai.2.3.298-303.1970
Novotny, J F, and Hetrick, F M. "Pathogenesis and transmission of kilham rat virus infection in rats." Infection and immunity vol. 2,3 (1970): 298-303. doi: https://doi.org/10.1128/iai.2.3.298-303.1970
Novotny JF, Hetrick FM. Pathogenesis and transmission of kilham rat virus infection in rats. Infect Immun. 1970 Sep;2(3):298-303. doi: 10.1128/iai.2.3.298-303.1970. PMID: 16557835; PMCID: PMC416005.
Copy Download .nbib Format: NLM
Legume: alpha-GALACTOSIDASE FORMS DEVOID OF HEMAGGLUTININ ACTIVITY.

Plant physiology

Hankins CN, Kindinger JI, Shannon LM.
PMID: 16661439
Plant Physiol. 1980 Sep;66(3):375-8. doi: 10.1104/pp.66.3.375.

Twenty different legume species (20 genera) were examined for alpha-galactosidase and hemagglutinin activities. Although all of the species contained enzyme activity, only 13 of 20 contained hemagglutinin activities and none displayed a hemagglutinin activity comparable to the previously described...

Cite
Hankins CN, Kindinger JI, Shannon LM. Legume: alpha-GALACTOSIDASE FORMS DEVOID OF HEMAGGLUTININ ACTIVITY. Plant Physiol. 1980;66(3):375-8doi: 10.1104/pp.66.3.375.
Hankins, C. N., Kindinger, J. I., & Shannon, L. M. (1980). Legume: alpha-GALACTOSIDASE FORMS DEVOID OF HEMAGGLUTININ ACTIVITY. Plant physiology, 66(3), 375-8. https://doi.org/10.1104/pp.66.3.375
Hankins, C N, et al. "Legume: alpha-GALACTOSIDASE FORMS DEVOID OF HEMAGGLUTININ ACTIVITY." Plant physiology vol. 66,3 (1980): 375-8. doi: https://doi.org/10.1104/pp.66.3.375
Hankins CN, Kindinger JI, Shannon LM. Legume: alpha-GALACTOSIDASE FORMS DEVOID OF HEMAGGLUTININ ACTIVITY. Plant Physiol. 1980 Sep;66(3):375-8. doi: 10.1104/pp.66.3.375. PMID: 16661439; PMCID: PMC440637.
Copy Download .nbib Format: NLM
ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS.

The Journal of experimental medicine

Hirst GK.
PMID: 19871229
J Exp Med. 1942 Aug 01;76(2):195-209. doi: 10.1084/jem.76.2.195.

A number of experiments were performed on the adsorption of influenza hemagglutinins on chicken red blood cells, from which the following conclusions were drawn:- 1. When chicken red blood cells and preparations of influenza viruses were mixed together, the...

Cite
Hirst GK. ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS. J Exp Med. 1942;76(2):195-209doi: 10.1084/jem.76.2.195.
Hirst, G. K. (1942). ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS. The Journal of experimental medicine, 76(2), 195-209. https://doi.org/10.1084/jem.76.2.195
Hirst, G K. "ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS." The Journal of experimental medicine vol. 76,2 (1942): 195-209. doi: https://doi.org/10.1084/jem.76.2.195
Hirst GK. ADSORPTION OF INFLUENZA HEMAGGLUTININS AND VIRUS BY RED BLOOD CELLS. J Exp Med. 1942 Aug 01;76(2):195-209. doi: 10.1084/jem.76.2.195. PMID: 19871229; PMCID: PMC2135226.
Copy Download .nbib Format: NLM
THE RELATION OF THE HYPOPHYSIS TO ANTIBODY PRODUCTION.

The Journal of experimental medicine

Cutler EC.
PMID: 19868602
J Exp Med. 1922 Jan 31;35(2):243-56. doi: 10.1084/jem.35.2.243.

An operative technique was evolved permitting successful partial hypophysectomy in guinea pigs. Such animals, when immunized to Bacillus typhosus, produced specific agglutinins in the same quantity and at the same rate as unoperated and operation controls immunized at the...

Cite
Cutler EC. THE RELATION OF THE HYPOPHYSIS TO ANTIBODY PRODUCTION. J Exp Med. 1922;35(2):243-56doi: 10.1084/jem.35.2.243.
Cutler, E. C. (1922). THE RELATION OF THE HYPOPHYSIS TO ANTIBODY PRODUCTION. The Journal of experimental medicine, 35(2), 243-56. https://doi.org/10.1084/jem.35.2.243
Cutler, E C. "THE RELATION OF THE HYPOPHYSIS TO ANTIBODY PRODUCTION." The Journal of experimental medicine vol. 35,2 (1922): 243-56. doi: https://doi.org/10.1084/jem.35.2.243
Cutler EC. THE RELATION OF THE HYPOPHYSIS TO ANTIBODY PRODUCTION. J Exp Med. 1922 Jan 31;35(2):243-56. doi: 10.1084/jem.35.2.243. PMID: 19868602; PMCID: PMC2128098.
Copy Download .nbib Format: NLM
HEMOLYSINS OF VEGETABLE ORIGIN.

The Journal of experimental medicine

Kritchevsky IL.
PMID: 19868173
J Exp Med. 1917 Nov 01;26(5):669-86. doi: 10.1084/jem.26.5.669.

1. The sap of Cotyledon scheideckeri possesses hemolysins for the red corpuscles of different animals. 2. The hemolysins of vegetable sap can be bound by erythrocytes and cannot be separated. 3. A definite quantity of erythrocytes is able to...

Cite
Kritchevsky IL. HEMOLYSINS OF VEGETABLE ORIGIN. J Exp Med. 1917;26(5):669-86doi: 10.1084/jem.26.5.669.
Kritchevsky, I. L. (1917). HEMOLYSINS OF VEGETABLE ORIGIN. The Journal of experimental medicine, 26(5), 669-86. https://doi.org/10.1084/jem.26.5.669
Kritchevsky, I L. "HEMOLYSINS OF VEGETABLE ORIGIN." The Journal of experimental medicine vol. 26,5 (1917): 669-86. doi: https://doi.org/10.1084/jem.26.5.669
Kritchevsky IL. HEMOLYSINS OF VEGETABLE ORIGIN. J Exp Med. 1917 Nov 01;26(5):669-86. doi: 10.1084/jem.26.5.669. PMID: 19868173; PMCID: PMC2125798.
Copy Download .nbib Format: NLM
ANTIBODY PRODUCTION AFTER PARTIAL ADRENALECTOMY IN GUINEA PIGS.

The Journal of experimental medicine

Gates FL.
PMID: 19868237
J Exp Med. 1918 Jun 01;27(6):725-38. doi: 10.1084/jem.27.6.725.

By careful aseptic operation it was found possible to remove approximately three-quarters to seven-eighths of the adrenal tissue of guinea pigs without causing symptoms of adrenal insufficiency. Guinea pigs were immunized to Bacillus typhosus or to hen corpuscles at...

Cite
Gates FL. ANTIBODY PRODUCTION AFTER PARTIAL ADRENALECTOMY IN GUINEA PIGS. J Exp Med. 1918;27(6):725-38doi: 10.1084/jem.27.6.725.
Gates, F. L. (1918). ANTIBODY PRODUCTION AFTER PARTIAL ADRENALECTOMY IN GUINEA PIGS. The Journal of experimental medicine, 27(6), 725-38. https://doi.org/10.1084/jem.27.6.725
Gates, F L. "ANTIBODY PRODUCTION AFTER PARTIAL ADRENALECTOMY IN GUINEA PIGS." The Journal of experimental medicine vol. 27,6 (1918): 725-38. doi: https://doi.org/10.1084/jem.27.6.725
Gates FL. ANTIBODY PRODUCTION AFTER PARTIAL ADRENALECTOMY IN GUINEA PIGS. J Exp Med. 1918 Jun 01;27(6):725-38. doi: 10.1084/jem.27.6.725. PMID: 19868237; PMCID: PMC2126073.
Copy Download .nbib Format: NLM
Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm.

Clinical ophthalmology (Auckland, N.Z.)

Park J, Lee MS, Harrison AR.
PMID: 21691580
Clin Ophthalmol. 2011;5:725-32. doi: 10.2147/OPTH.S13978. Epub 2011 Jun 01.

Even though conventional botulinum neurotoxin (BoNT) products have shown successful treatment results in patients with benign blepharospasm (BEB), the main, potential long-term side effect of BoNT use is the development of immunologic resistance due to the production of neutralizing...

Cite
Park J, Lee MS, Harrison AR. Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol. 2011;5:725-32doi: 10.2147/OPTH.S13978.
Park, J., Lee, M. S., & Harrison, A. R. (2011). Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clinical ophthalmology (Auckland, N.Z.), 5725-32. https://doi.org/10.2147/OPTH.S13978
Park, Juwan, et al. "Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm." Clinical ophthalmology (Auckland, N.Z.) vol. 5 (2011): 725-32. doi: https://doi.org/10.2147/OPTH.S13978
Park J, Lee MS, Harrison AR. Profile of Xeomin® (incobotulinumtoxinA) for the treatment of blepharospasm. Clin Ophthalmol. 2011;5:725-32. doi: 10.2147/OPTH.S13978. Epub 2011 Jun 01. PMID: 21691580; PMCID: PMC3116796.
Copy Download .nbib Format: NLM
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains.

NPJ vaccines

Broecker F, Liu STH, Suntronwong N, Sun W, Bailey MJ, Nachbagauer R, Krammer F, Palese P.
PMID: 31341648
NPJ Vaccines. 2019 Jul 19;4:31. doi: 10.1038/s41541-019-0126-4. eCollection 2019.

Current seasonal influenza virus vaccines only provide limited, short-lived protection, and antigenic drift in the hemagglutinin surface glycoprotein necessitates their annual re-formulation and re-administration. To overcome these limitations, universal vaccine strategies that aim at eliciting broadly protective antibodies to...

Cite
Broecker F, Liu STH, Suntronwong N, et al. A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. NPJ Vaccines. 2019;4:31doi: 10.1038/s41541-019-0126-4.
Broecker, F., Liu, S. T. H., Suntronwong, N., Sun, W., Bailey, M. J., Nachbagauer, R., Krammer, F., & Palese, P. (2019). A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. NPJ vaccines, 431. https://doi.org/10.1038/s41541-019-0126-4
Broecker, Felix, et al. "A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains." NPJ vaccines vol. 4 (2019): 31. doi: https://doi.org/10.1038/s41541-019-0126-4
Broecker F, Liu STH, Suntronwong N, Sun W, Bailey MJ, Nachbagauer R, Krammer F, Palese P. A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains. NPJ Vaccines. 2019 Jul 19;4:31. doi: 10.1038/s41541-019-0126-4. eCollection 2019. PMID: 31341648; PMCID: PMC6642189.
Copy Download .nbib Format: NLM
Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans.

mSphere

Stadlbauer D, Rajabhathor A, Amanat F, Kaplan D, Masud A, Treanor JJ, Izikson R, Cox MM, Nachbagauer R, Krammer F.
PMID: 29242836
mSphere. 2017 Dec 13;2(6). doi: 10.1128/mSphere.00502-17. eCollection 2017.

Human influenza virus infections with avian subtype H7N9 viruses are a major public health concern and have encouraged the development of effective H7 prepandemic vaccines. In this study, baseline and postvaccination serum samples of individuals aged 18 years and...

Cite
Stadlbauer D, Rajabhathor A, Amanat F, et al. Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans. mSphere. 2017;2(6)doi: 10.1128/mSphere.00502-17.
Stadlbauer, D., Rajabhathor, A., Amanat, F., Kaplan, D., Masud, A., Treanor, J. J., Izikson, R., Cox, M. M., Nachbagauer, R., & Krammer, F. (2017). Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans. mSphere, 2(6), . https://doi.org/10.1128/mSphere.00502-17
Stadlbauer, Daniel, et al. "Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans." mSphere vol. 2,6 (2017). doi: https://doi.org/10.1128/mSphere.00502-17
Stadlbauer D, Rajabhathor A, Amanat F, Kaplan D, Masud A, Treanor JJ, Izikson R, Cox MM, Nachbagauer R, Krammer F. Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans. mSphere. 2017 Dec 13;2(6). doi: 10.1128/mSphere.00502-17. eCollection 2017. PMID: 29242836; PMCID: PMC5729220.
Copy Download .nbib Format: NLM
Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses.

Nature immunology

Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS.
PMID: 30980067
Nat Immunol. 2019 Jun;20(6):765. doi: 10.1038/s41590-019-0395-0.

In the version of this article initially published, the labels (50 Å) above the scale bars in Fig. 1b were incorrect. The correct size is 50 nm. The error has been corrected in the HTML and PDF versions of...

Cite
Kanekiyo M, Joyce MG, Gillespie RA, et al. Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nat Immunol. 2019;20(6):765doi: 10.1038/s41590-019-0395-0.
Kanekiyo, M., Joyce, M. G., Gillespie, R. A., Gallagher, J. R., Andrews, S. F., Yassine, H. M., Wheatley, A. K., Fisher, B. E., Ambrozak, D. R., Creanga, A., Leung, K., Yang, E. S., Boyoglu-Barnum, S., Georgiev, I. S., Tsybovsky, Y., Prabhakaran, M. S., Andersen, H., Kong, W. P., Baxa, U., Zephir, K. L., Ledgerwood, J. E., Koup, R. A., Kwong, P. D., Harris, A. K., McDermott, A. B., Mascola, J. R., & Graham, B. S. (2019). Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nature immunology, 20(6), 765. https://doi.org/10.1038/s41590-019-0395-0
Kanekiyo, Masaru, et al. "Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses." Nature immunology vol. 20,6 (2019): 765. doi: https://doi.org/10.1038/s41590-019-0395-0
Kanekiyo M, Joyce MG, Gillespie RA, Gallagher JR, Andrews SF, Yassine HM, Wheatley AK, Fisher BE, Ambrozak DR, Creanga A, Leung K, Yang ES, Boyoglu-Barnum S, Georgiev IS, Tsybovsky Y, Prabhakaran MS, Andersen H, Kong WP, Baxa U, Zephir KL, Ledgerwood JE, Koup RA, Kwong PD, Harris AK, McDermott AB, Mascola JR, Graham BS. Author Correction: Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses. Nat Immunol. 2019 Jun;20(6):765. doi: 10.1038/s41590-019-0395-0. PMID: 30980067.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 60 entries